A detailed history of Financial Security Advisor, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Security Advisor, Inc. holds 3,100 shares of ABBV stock, worth $532,363. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,100
Previous 3,162 1.96%
Holding current value
$532,363
Previous $542 Million 12.88%
% of portfolio
0.15%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$163.84 - $199.33 $10,158 - $12,358
-62 Reduced 1.96%
3,100 $612 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $14,395 - $16,810
93 Added 3.03%
3,162 $542 Million
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $16,301 - $18,574
-102 Reduced 3.22%
3,069 $559 Million
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $18,851 - $21,230
137 Added 4.52%
3,171 $491 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $405,312 - $469,208
3,034 New
3,034 $452 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Security Advisor, Inc. Portfolio

Follow Financial Security Advisor, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Security Advisor, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Security Advisor, Inc. with notifications on news.